Nektar Therapeutics (NKTR) Short-term Investments (2010 - 2026)
Nektar Therapeutics' Short-term Investments was $645.07 million in Q2 2026, up 385.3% from $132.92 million a year earlier and up 53.9% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Short-term Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Nektar Therapeutics came in at $230.64 million, up 9.3% from FY2024.
- Short-term Investments shows a five-year compound annual growth rate of -23.2% (FY2020 to FY2025).
- In earlier years, Short-term Investments was $210.97 million in FY2024 (-21.4%), $268.34 million in FY2023 (-35.6%), $416.75 million in FY2022 (-41.2%) and $708.74 million in FY2021 (-17.9%).
- The Q2 2026 figure marks the highest quarterly Short-term Investments since Q4 2021.
- Compared with a year earlier, Short-term Investments has increased for four straight quarters, with growth averaging 51.5% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q2 2026 (growth of 385.3%); the worst was Q3 2022 (a decline of 49.2%).
- Per Business Quant data, NKTR's Short-term Investments in the three quarters before Q2 2026 was $419.03 million (Q1 2026), $230.64 million (Q4 2025) and $229.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Nektar Therapeutics | 1.44 Bn | -328.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 645.07 Mn |
| Mar 31, 2026 | 419.03 Mn |
| Dec 31, 2025 | 230.64 Mn |
| Sep 30, 2025 | 229.18 Mn |
| Jun 30, 2025 | 132.92 Mn |
| Mar 31, 2025 | 179.74 Mn |
| Dec 31, 2024 | 210.97 Mn |
| Sep 30, 2024 | 214.39 Mn |
| Jun 30, 2024 | 243.30 Mn |
| Mar 31, 2024 | 240.60 Mn |
| Dec 31, 2023 | 268.34 Mn |
| Sep 30, 2023 | 307.74 Mn |
| Jun 30, 2023 | 358.70 Mn |
| Mar 31, 2023 | 379.87 Mn |
| Dec 31, 2022 | 416.75 Mn |
| Sep 30, 2022 | 440.63 Mn |
| Jun 30, 2022 | 541.77 Mn |
| Mar 31, 2022 | 599.03 Mn |
| Dec 31, 2021 | 708.74 Mn |
| Sep 30, 2021 | 867.06 Mn |
API Access
Nektar Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();